CSIMarket Company Name, Ticker, Competitors, else..


Pieris Pharmaceuticals Inc   (NASDAQ: PIRS)
Other Ticker:  
 

Pieris Pharmaceuticals Inc

PIRS's Fundamental analysis



Pieris Pharmaceuticals Inc 's sales fell in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 211

Major Pharmaceutical Preparations industry recorded growth of revenues by 9.75 %

Pieris Pharmaceuticals Inc net loss decreased from $-11 millions, to $-3 millions in III. Quarter 2024,

• More on PIRS's Growth


Pieris Pharmaceuticals Inc
realized a net loss in trailing twelve months.

Pieris Pharmaceuticals Inc realized cash reduction of $ -10.25 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 13.28.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.21.


• More on PIRS's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 12.32

Pieris Pharmaceuticals Inc
realized net loss in trailing twelve months.

Pieris Pharmaceuticals Inc realized cash outflow of $ -10.25per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 13.28.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.21.

Pieris Pharmaceuticals Inc Price to Book Ratio is at 1.1 lower than Industry Avg. of 429.04. and higher than S&P 500 Avg. of 0.02

• More on PIRS's Valuation

•  Market Capitalization (Millions $) 18
•  Shares Outstanding (Millions) 1
•  Employees 30
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -16
•  Cash Flow (TTM) (Millions $) -14
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 12.32

•  Market Capitalization (Millions $) 18
•  Shares Outstanding (Millions) 1
•  Employees 30
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -16
•  Cash Flow (TTM) (Millions $) -14
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 25.62
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.05
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com